ADAR1 Capital Management’s Ventyx Biosciences VTYX Stock Holding History

ADAR1 Capital Management’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-81,600	Closed	-$737K	–	343
2025 Q4	$737K	Hold	81,600	–	–	0.05%	160
2025 Q3	$254K	Sell	81,600 -87,000	-52%	-$230K	0.02%	170
2025 Q2	$361K	Sell	168,600 -113,000	-40%	-$183K	0.06%	132
2025 Q1	$324K	Buy	281,600 +157,070	+126%	+$270K	0.06%	126
2024 Q4	$273K	Buy	124,530 +26,575	+27%	+$60.2K	0.05%	140
2024 Q3	$214K	Buy	97,955 +85,000	+656%	+$195K	0.03%	159
2024 Q2	$29.9K	Buy	12,955 +7,955	+159%	+$33.1K	0.01%	206
2024 Q1	$27.5K	Sell	5,000 -8,000	-62%	-$36.6K	0.01%	210
2023 Q4	$32.1K	Buy	+13,000	New	+$123K	0.01%	126

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADAR1 Capital Management's VTYX Position: Q1 2026 in Review

ADAR1 Capital Management sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 81,600 shares — an estimated $737K sold.

ADAR1 Capital Management first reported a position in VTYX in Q4 2023 and held it in 9 quarters. The position peaked at $737K in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

ADAR1 Capital Management reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
ADAR1 Capital Management sold 81,600 Ventyx Biosciences shares in Q1 2026, an estimated $737K.
ADAR1 Capital Management first reported a position in Ventyx Biosciences in Q4 2023 and held it in 9 quarters.
ADAR1 Capital Management's Ventyx Biosciences position peaked at $737K in Q4 2025.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.